{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:02:12Z","timestamp":1790830932192,"version":"4.1.0"},"reference-count":230,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Although vaccines have already saved and will continue to save millions of lives, they are under attack. Vaccine safety is the main target of criticism. The rapid distribution of false information, or even conspiracy theories on the internet has tremendously favored vaccine hesitancy. The World Health Organization (WHO) named vaccine hesitancy one of the top ten threats to global health in 2019. Parents and patients have several concerns about vaccine safety, of which the ubiquitous anxieties include inactivating agents, adjuvants, preservatives, or new technologies such as genetic vaccines. In general, increasing doubts concerning side effects have been observed, which may lead to an increasing mistrust of scientific results and thus, the scientific method. Hence, this review targets five topics concerning vaccines and reviews current scientific publications in order to summarize the available information refuting conspiracy theories and myths about vaccination. The topics have been selected based on the author\u2019s personal perception of the most frequently occurring safety controversies: the inactivation agent formaldehyde, the adjuvant aluminum, the preservative mercury, the mistakenly-drawn correlation between vaccines and autism and genetic vaccines. The scientific literature shows that vaccine safety is constantly studied. Furthermore, the literature does not support the allegations that vaccines may cause a serious threat to general human life. The author suggests that more researchers explaining their research ideas, methods and results publicly could strengthen the general confidence in science. In general, vaccines present one of the safest and most cost-effective medications and none of the targeted topics raised serious health concerns.<\/jats:p>","DOI":"10.3389\/fimmu.2021.663280","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T09:29:25Z","timestamp":1623317365000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["Review: Vaccine Myth-Buster \u2013 Cleaning Up With Prejudices and Dangerous Misinformation"],"prefix":"10.3389","volume":"12","author":[{"given":"Paul","family":"L\u00f6ffler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/ejsp.2157","article-title":"Sometimes Inclusion Breeds Suspicion: Self-Uncertainty and Belongingness Predict Belief in Conspiracy Theories: Self-Uncertainty and Conspiracy Beliefs","volume":"46","author":"van Prooijen","year":"2016","journal-title":"Eur J Soc Psychol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1177\/1750698017701615","article-title":"Conspiracy Theories as Part of History: The Role of Societal Crisis Situations","volume":"10","author":"van Prooijen","year":"2017","journal-title":"Memory Stud"},{"key":"B3","doi-asserted-by":"crossref","DOI":"10.1525\/california\/9780520247871.001.0001","volume-title":"The Rhetoric of Conspiracy in Ancient Athens","author":"Roisman","year":"2006"},{"key":"B4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1215\/0094033X-2007-017","article-title":"Toward a Model of Conspiracy Theory for Ancient Rome","volume":"35","author":"Pag\u00e1n","year":"2008","journal-title":"New German Critique"},{"key":"B5","doi-asserted-by":"crossref","DOI":"10.5040\/9781472944528","volume-title":"Suspicious Minds: Why We Believe Conspiracy Theories","author":"Brotherton","year":"2015"},{"key":"B6","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/ejsp.2530","article-title":"Belief in Conspiracy Theories: Basic Principles of an Emerging Research Domain","volume":"48","author":"van Prooijen","year":"2018","journal-title":"Eur J Soc Psychol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"pii=19852","DOI":"10.2807\/ese.16.17.19849-en","article-title":"Innovations in Communication: The Internet and the Psychology of Vaccination Decisions","volume":"16","author":"Betsch","year":"2011","journal-title":"Eurosuveillance"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4415\/ANN_14_01_03","article-title":"Contrasting the Anti-Vaccine Prejudice: A Public Health Perspective","volume":"50","author":"Stefanelli","year":"2014","journal-title":"Ann Ist Super Sanit\u00e0"},{"key":"B9","doi-asserted-by":"publisher","first-page":"113356","DOI":"10.1016\/j.socscimed.2020.113356","article-title":"Conspiracy Theories as Barriers to Controlling the Spread of COVID-19 in the U.S","volume":"263","author":"Romer","year":"2020","journal-title":"Soc Sci Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00372","article-title":"Vaccine Safety: Myths and Misinformation","volume":"11","author":"Geoghegan","year":"2020","journal-title":"Front Microbiol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2005.11928028","article-title":"Edward Jenner and the History of Smallpox and Vaccination","volume":"18","author":"Riedel","year":"2005","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.24.3.611","article-title":"The History of Vaccines and Immunization: Familiar Patterns, New Challenges","volume":"24","author":"Stern","year":"2005","journal-title":"Health Affairs"},{"key":"B13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.20506\/rst.26.1.1724","article-title":"A Brief History of Vaccines and Vaccination: -En- A Brief History of Vaccines and Vaccination -Fr- Une Br\u00e8ve Histoire Des Vaccins Et De La Vaccination -Es- Una Breve Historia De Las Vacunas Y La Vacunaci\u00f3n","volume":"26","author":"Lombard","year":"2007","journal-title":"Rev Sci Tech OIE"},{"key":"B14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1586\/14760584.2015.964212","article-title":"Vaccine Hesitancy, Vaccine Refusal and the Anti-Vaccine Movement: Influence, Impact and Implications","volume":"14","author":"Dub\u00e9","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"B15","unstructured":"Ten Health Issues WHO Will Tackle This Year"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)04334-1","article-title":"Impact of Anti-Vaccine Movements on Pertussis Control: The Untold Story","volume":"351","author":"Gangarosa","year":"1998","journal-title":"Lancet"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1542\/peds.106.5.1097","article-title":"Committee\u2225 for the NN for IIS. do Parents Understand Immunizations? A National Telephone Survey","volume":"106","author":"Gellin","year":"2000","journal-title":"Pediatrics"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1126\/science.1086726","article-title":"Measles Outbreaks in a Population With Declining Vaccine Uptake","volume":"301","author":"Jansen","year":"2003","journal-title":"Science"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2017.09.014","article-title":"Contents of Japanese Pro- and Anti-HPV Vaccination Websites: A Text Mining Analysis","volume":"101","author":"Okuhara","year":"2018","journal-title":"Patient Educ Counseling"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/318323a0","article-title":"Vaccination and Herd Immunity to Infectious Diseases","volume":"318","author":"Anderson","year":"1985","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1023\/A:1007626510002","article-title":"Herd Immunity and Herd Effect: New Insights and Definitions","volume":"16","author":"John","year":"2000","journal-title":"Eur J Epidemiol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir007","article-title":"\u201cHerd Immunity\u201d: A Rough Guide","volume":"52","author":"Fine","year":"2011","journal-title":"Clin Infect Dis"},{"key":"B23","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM198011273032204","volume-title":"The Confirmation and Maintenance of Smallpox Eradication","author":"Breman","year":"1980"},{"key":"B24","article-title":"Principles and Lessons From the Smallpox Eradication Programme","volume":"65","author":"Henderson\u2019","year":"1987","journal-title":"Bull World Health Organ"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.06.080","article-title":"The Eradication of Smallpox \u2013 An Overview of the Past, Present, and Future","author":"Henderson","year":"2011","journal-title":"Vaccine"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.01.080","article-title":"The Expanded Programme on Immunization: A Lasting Legacy of Smallpox Eradication","volume":"29","author":"Okwo-Bele","year":"2011","journal-title":"Vaccine"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/v12020138","article-title":"Smallpox in the Post-Eradication Era","volume":"12","author":"Meyer","year":"2020","journal-title":"Viruses"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0b013e3280555160","article-title":"Vaccination, Seizures and \u2018Vaccine Damage.\u2019","volume":"20","author":"Brown","year":"2007","journal-title":"Curr Opin Neurology"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70238-X","article-title":"Pandemic Influenza A H1N1 Vaccines and Narcolepsy: Vaccine Safety Surveillance in Action","volume":"14","author":"Barker","year":"2014","journal-title":"Lancet Infect Diseases"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2017.06.006","article-title":"Incidence of Narcolepsy After H1N1 Influenza and Vaccinations: Systematic Review and Meta-Analysis","volume":"38","author":"Sarkanen","year":"2018","journal-title":"Sleep Med Rev"},{"key":"B31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11910-018-0851-5","article-title":"Narcolepsy Associated With Pandemrix Vaccine","volume":"18","author":"Sarkanen","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2016.100","article-title":"Narcolepsy","volume":"3","author":"Kornum","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1086\/318799","article-title":"Complex HLA-DR and -DQ Interactions Confer Risk of Narcolepsy-Cataplexy in Three Ethnic Groups","volume":"68","author":"Mignot","year":"2001","journal-title":"Am J Hum Genet"},{"key":"B34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.5665\/sleep.3300","article-title":"Dqb1 Locus Alone Explains Most of the Risk and Protection in Narcolepsy With Cataplexy in Europe","volume":"37","author":"Tafti","year":"2014","journal-title":"Sleep"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1080\/08916934.2016.1183655","article-title":"Autoantibody Targets in Vaccine-Associated Narcolepsy","volume":"49","author":"H\u00e4ggmark-M\u00e5nberg","year":"2016","journal-title":"Autoimmunity"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f794","article-title":"Risk of Narcolepsy in Children and Young People Receiving As03 Adjuvanted Pandemic A\/H1N1 2009 Influenza Vaccine: Retrospective Analysis","volume":"346","author":"Miller","year":"2013","journal-title":"BMJ"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e33536","DOI":"10.1371\/journal.pone.0033536","article-title":"As03 Adjuvanted Ah1n1 Vaccine Associated With an Abrupt Increase in the Incidence of Childhood Narcolepsy in Finland","volume":"7","author":"Nohynek","year":"2012","journal-title":"PLoS One"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.04.058","article-title":"Challenges in Conducting Post-Authorisation Safety Studies (Pass): A Vaccine Manufacturer\u2019s View","volume":"35","author":"Cohet","year":"2017","journal-title":"Vaccine"},{"key":"B39","volume-title":"Pandemrix Influenza Vaccine (H1n1)V (Split Virion, Inactivated, Adjuvanted)","year":"2016"},{"key":"B40","volume-title":"Questions and Answers on COVID-19 Vaccination in the EU","year":"2020"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.2105\/ajph.24.1.22","article-title":"Diphteria Toxoid as an Immunizing Agent","volume":"4","author":"Glenny","year":"1923","journal-title":"Br J Exp Pathol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2013.04.016","article-title":"Formulation Approach for the Development of a Stable, Lyophilized Formaldehyde-Containing Vaccine","volume":"85","author":"Clausi","year":"2013","journal-title":"Eur J Pharmaceutics Biopharmaceutics"},{"key":"B43","unstructured":"Note for Guidance on Harmonisation of Requirements for Influenza Vaccines1997"},{"key":"B44","article-title":"Summary Minutes - 142nd Vaccines and Related Biological Products Advisory Committtee Meeting","author":"Edwards","year":"2016","journal-title":"Conference Report of the FDA"},{"key":"B45","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1863-2378.2007.01029.x","article-title":"Inactivation of Avian Influenza Viruses by Chemical Agents and Physical Conditions: A Review","volume":"54","author":"De Benedictis","year":"2007","journal-title":"Zoonoses Public Health"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(94)90259-3","article-title":"Toxin Inactivation and Antigen Stabilization: Two Different Uses of Formaldehyde","volume":"12","author":"Rappuoli","year":"1994","journal-title":"Vaccine"},{"key":"B47","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/B978-1-4160-3611-1.50010-6","article-title":"Chapter 6 - Vaccine Additives and Manufacturing Residuals in United States-Licensed Vaccines","volume-title":"Vaccines","author":"Finn","year":"2008"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.279232","article-title":"Reactions of \u03b2-Propiolactone With Nucleobase Analogues, Nucleosides, and Peptides","volume":"286","author":"Uittenbogaard","year":"2011","journal-title":"J\u00a0Biol Chem"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.018168-0","article-title":"Effect of Inactivation Method on the Cross-Protective Immunity Induced by Whole \u201cKilled\u201d Influenza A Viruses and Commercial Vaccine Preparations","volume":"91","author":"Furuya","year":"2010","journal-title":"J Gen Virology"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2014.07.003","article-title":"Hydrogen Peroxide Inactivation of Influenza Virus Preserves Antigenic Structure and Immunogenicity","volume":"207","author":"Dembinski","year":"2014","journal-title":"J Virological Methods"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.01.086","article-title":"Inactivated or Damaged? Comparing the Effect of Inactivation Methods on Influenza Virions to Optimize Vaccine Production","volume":"37","author":"Herrera-Rodriguez","year":"2019","journal-title":"Vaccine"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.12.043","article-title":"Effect of Aluminum Hydroxide Adjuvant and Formaldehyde in the Formulation of Rpa Anthrax Vaccine","volume":"25","author":"Little","year":"2007","journal-title":"Vaccine"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02045-09","article-title":"Influenza Virus Inactivation for Studies of Antigenicity and Phenotypic Neuraminidase Inhibitor Resistance Profiling","volume":"48","author":"Jonges","year":"2010","journal-title":"J Clin Microbiol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00999-09","article-title":"Formaldehyde-Inactivated Whole-Virus Vaccine Protects a Murine Model of Enterovirus 71 Encephalomyelitis Against Disease","volume":"84","author":"Ong","year":"2010","journal-title":"JVI"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.11.031","article-title":"Flagellin Enhances the Immunoprotection of Formalin-Inactivated Edwardsiella Tarda Vaccine in Turbot","volume":"35","author":"Liu","year":"2017","journal-title":"Vaccine"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.fsi.2017.04.008","article-title":"A Formalin-Inactivated Vaccine Provides Good Protection Against Vibrio Harveyi Infection in Orange-Spotted Grouper (Epinephelus Coioides)","volume":"65","author":"Nguyen","year":"2017","journal-title":"Fish Shellfish Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.08.037","article-title":"A Comparative Study of the Effect of UV and Formalin Inactivation on the Stability and Immunogenicity of a Coxsackievirus B1 Vaccine","volume":"37","author":"Hankaniemi","year":"2019","journal-title":"Vaccine"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/jfd.13260","article-title":"Efficacy of a Formalin-Inactivated Lactococcus Garvieae Vaccine in Farmed Grey Mullet (Mugil Cephalus)","volume":"43","author":"Rao","year":"2020","journal-title":"J Fish Dis"},{"key":"B59","first-page":"1","article-title":"Reactions of Nucleic Acids and NucleoDroteins With Formaldehyde","volume-title":"Progress in Nucleic Acid Research and Molecular Biology","author":"Feldman","year":"1973"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.12.033","article-title":"Investigation of the Detoxification Mechanism of Formaldehyde-Treated Tetanus Toxin","volume":"25","author":"Thaysen-Andersen","year":"2007","journal-title":"Vaccine"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R115.651679","article-title":"Formaldehyde Crosslinking: A Tool for the Study of Chromatin Complexes","volume":"290","author":"Hoffman","year":"2015","journal-title":"J Biol Chem"},{"key":"B62","doi-asserted-by":"publisher","first-page":"32074","DOI":"10.1002\/rmv.2074","article-title":"Inactivation Methods for Whole Influenza Vaccine Production","volume":"29","author":"Sabbaghi","year":"2019","journal-title":"Rev Med Virol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1637\/8343-050208-Reg.1","article-title":"Reduced Egg Production in Hens Associated With Avian Influenza Vaccines and Formalin Levels","volume":"53","author":"Meng","year":"2009","journal-title":"Avian Diseases"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrrev.2011.07.003","article-title":"Reproductive and Developmental Toxicity of Formaldehyde: A Systematic Review","volume":"728","author":"Duong","year":"2011","journal-title":"Mutat Research\/Reviews Mutat Res"},{"key":"B65","volume-title":"Opinion on the Application for Approval of the Active Substance: Formaldehyde Product Type 3","year":"2019"},{"key":"B66","volume-title":"Opinion on the Application for Approval of the Active Substance Formaldehyde Product Type 2","year":"2019"},{"key":"B67","volume-title":"Who Guidelines for Indoor Air Quality: Selected Pollutants","year":"2010"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1007\/BF01292437","article-title":"Determination of Formaldehyde in Foods","volume":"142","author":"M\u00f6hler","year":"1970","journal-title":"Z f\u00fcr Lebensmittel-Untersuchung und -Forschung"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2005.09.089","article-title":"Fish and Food Safety: Determination of Formaldehyde in 12 Fish Species by SPME Extraction and GC\u2013MS Analysis","volume":"100","author":"Bianchi","year":"2007","journal-title":"Food Chem"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.5923\/j.fph.20130301.06","article-title":"Health Risk Assessment of Adults Consuming Commercial Fish Contaminated With Formaldehyde","volume":"3","author":"Aminah","year":"2013","journal-title":"Food Public Health"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2016.01.136","article-title":"Determination of Formaldehyde in Food and Feed by an in-House Validated Hplc Method","volume":"202","author":"Wahed","year":"2016","journal-title":"Food Chem"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.01.024","article-title":"The Science of Vaccine Safety: Summary of Meeting at Wellcome Trust","volume":"38","author":"Plotkin","year":"2020","journal-title":"Vaccine"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2370(01)00185-1","article-title":"Formaldehyde in the Gas Phase of Mainstream Cigarette Smoke","volume":"65","author":"Li","year":"2002","journal-title":"J Analytical Appl Pyrolysis"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1413069","article-title":"Hidden Formaldehyde in E-Cigarette Aerosols","volume":"372","author":"Jensen","year":"2015","journal-title":"N Engl J Med"},{"key":"B75","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.cotox.2018.07.001","article-title":"Formaldehyde Metabolism and Its Impact on Human Health","volume":"9","author":"Reingruber","year":"2018","journal-title":"Curr Opin Toxicology"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2015.08.020","article-title":"Endogenous Formaldehyde Is a Hematopoietic Stem Cell Genotoxin and Metabolic Carcinogen","volume":"60","author":"Pontel","year":"2015","journal-title":"Mol Cell"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.2173","article-title":"Formaldehyde Catabolism Is Essential in Cells Deficient for the Fanconi Anemia DNA-repair Pathway","volume":"18","author":"Rosado","year":"2011","journal-title":"Nat Struct Mol Biol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/nature04433","article-title":"Histone Demethylation by a Family of JmjC Domain-Containing Proteins","volume":"439","author":"Tsukada","year":"2006","journal-title":"Nature"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R115.656462","article-title":"The AlkB Family of Fe(II)\/\u03b1-Ketoglutarate-Dependent Dioxygenases: Repairing Nucleic Acid Alkylation Damage and Beyond","volume":"290","author":"Fedeles","year":"2015","journal-title":"J Biol Chem"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/nature23481","article-title":"Mammals Divert Endogenous Genotoxic Formaldehyde Into One-Carbon Metabolism","volume":"548","author":"Burgos-Barragan","year":"2017","journal-title":"Nature"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1007\/s00103-009-0961-y","article-title":"Sicherheit Von Impfstoffen","volume":"52","author":"Wei\u00dfer","year":"2009","journal-title":"Bundesgesundheitsbl"},{"key":"B82","first-page":"945","volume-title":"Vaccines for Human Use","year":"1999"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-005-0405-0","article-title":"Relevance of Additives and Adjuvants in Vaccines for Allergic and Toxic Side Effects","volume":"117","author":"Wiedermann-Schmidt","year":"2005","journal-title":"Wien Klin Wochenschr"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.03.071","article-title":"Pharmacokinetic Modeling as an Approach to Assessing the Safety of Residual Formaldehyde in Infant Vaccines","volume":"31","author":"Mitkus","year":"2013","journal-title":"Vaccine"},{"key":"B85","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/path.1700290106","article-title":"The Antigenic Value of Toxoid Precipitated by Potassium Alum","volume":"29","author":"Glenny","year":"1926","journal-title":"J Pathol Bacteriol"},{"key":"B86","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4615-1823-5_8","article-title":"Adjuvant Properties of Aluminum and Calcium Compounds","volume-title":"Vaccine Design: The Subunit and Adjuvant Approach [Internet]","author":"Gupta","year":"1995"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00166-4","article-title":"Aluminum Salts in Vaccines\u2014US Perspective","volume":"20","author":"Baylor","year":"2002","journal-title":"Vaccine"},{"key":"B88","doi-asserted-by":"publisher","first-page":"31578","DOI":"10.1038\/srep31578","article-title":"Insight Into the Cellular Fate and Toxicity of Aluminium Adjuvants Used in Clinically Approved Human Vaccinations","volume":"6","author":"Mold","year":"2016","journal-title":"Sci Rep"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2903\/j.efsa.2008.754","article-title":"Safety of Aluminium From Dietary Intake - Scientific Opinion of the Panel on Food Additives, Flavourings, Processing Aids and Food Contact Materials (Afc)","volume":"6","year":"2008","journal-title":"EFS2"},{"key":"B90","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1146\/annurev.nu.13.070193.000355","article-title":"Aluminum Metabolism","volume":"13","author":"Greger","year":"1993","journal-title":"Annu Rev Nutr"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1080\/02652039509374286","article-title":"Estimates of Dietary Exposure to Aluminium","volume":"12","author":"Pennington","year":"1995","journal-title":"Food Additives Contaminants"},{"key":"B92","first-page":"47","article-title":"Aluminium in Drinking Water: An Overview","volume":"25","author":"Srinivasan","year":"1999","journal-title":"Water SA"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1080\/19440040903490112","article-title":"Dietary Exposure to Aluminium of the Hong Kong Population","volume":"27","author":"Wong","year":"2010","journal-title":"Food Additives Contaminants: Part A"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12302-017-0116-y","article-title":"Migration of Aluminum From Food Contact Materials to Food\u2014a Health Risk for Consumers? Part I of III: Exposure to Aluminum, Release of Aluminum, Tolerable Weekly Intake (Twi), Toxicological Effects of Aluminum, Study Design, and Methods","volume":"29","author":"Stahl","year":"2017","journal-title":"Environ Sci Eur"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-019-02599-z","article-title":"Aggregated Aluminium Exposure: Risk Assessment for the General Population","volume":"93","author":"Tietz","year":"2019","journal-title":"Arch Toxicol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3109\/10408369709006422","article-title":"Aluminum Exposure and Metabolism","volume":"34","author":"Greger","year":"1997","journal-title":"Crit Rev Clin Lab Sci"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1992.tb00471.x","article-title":"Aluminium-Adjuvanted Vaccines Transiently Increase Aluminium Levels in Murine Brain Tissue","volume":"70","author":"Redhead","year":"1992","journal-title":"Pharmacol Toxicology"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600750613","article-title":"Absorption and Disposition of Aluminum in the Rat","volume":"75","author":"Gupta","year":"1986","journal-title":"J Pharm Sci"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/0041-008X(89)90118-X","article-title":"Elevated Aluminum Persists in Serum and Tissues of Rabbits After a Six-Hour Infusion","volume":"99","author":"Yokel","year":"1989","journal-title":"Toxicol Appl Pharmacol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1177\/096032719501400309","article-title":"Human Metabolism of aluminium-26 and Gallium-67 Injected as Citrates","volume":"14","author":"Priest","year":"1995","journal-title":"Hum Exp Toxicol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"bcr0920080951","DOI":"10.1136\/bcr.09.2008.0951","article-title":"Network on Behalf of the CISA (Cisa). Recurrent Sterile Abscesses Following Aluminium Adjuvant-Containing Vaccines","volume":"2009","author":"Klein","year":"2009","journal-title":"Case Rep"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-1600.2007.00055.x","article-title":"Elevated Urinary Aluminium in Current and Past Users of Illicit Heroin","volume":"12","author":"Exley","year":"2007","journal-title":"Addict Biol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/0300-483X(92)90159-C","article-title":"Assessment of Exposure to Parenteral and Oral Aluminum With and Without Citrate Using a Desferrioxamine Test in Rats","volume":"76","author":"Greger","year":"1992","journal-title":"Toxicology"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00170-6","article-title":"Elimination of Aluminum Adjuvants","volume":"20","author":"Hem","year":"2002","journal-title":"Vaccine"},{"key":"B105","doi-asserted-by":"crossref","DOI":"10.1007\/978-94-010-0167-0_16","article-title":"Lessons From Macrophagic Myofasciitis: Towards Definition of a Vaccine Adjuvant-Related Syndrome","volume-title":"Risk Science and Sustainability: Science for Reduction of Risk and Sustainable Development of Society","author":"Gherardi","year":"2003"},{"key":"B106","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.autrev.2019.05.006","article-title":"Myalgia and Chronic Fatigue Syndrome Following Immunization: Macrophagic Myofasciitis and Animal Studies Support Linkage to Aluminum Adjuvant Persistency and Diffusion in the Immune System","volume":"18","author":"Gherardi","year":"2019","journal-title":"Autoimmun Rev"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-013-8403-1","article-title":"Aluminum in the Central Nervous System (Cns): Toxicity in Humans and Animals, Vaccine Adjuvants, and Autoimmunity","volume":"56","author":"Shaw","year":"2013","journal-title":"Immunol Res"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10408444.2014.934439","article-title":"Systematic Review of Potential Health Risks Posed by Pharmaceutical, Occupational and Consumer Exposures to Metallic and Nanoscale Aluminum, Aluminum Oxides, Aluminum Hydroxide and Its Soluble Salts","volume":"44","author":"Willhite","year":"2014","journal-title":"Crit Rev Toxicology"},{"key":"B109","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jaut.2010.07.003","article-title":"\u2018Asia\u2019 \u2013 Autoimmune\/inflammatory Syndrome Induced by Adjuvants","volume":"36","author":"Shoenfeld","year":"2011","journal-title":"J Autoimmunity"},{"key":"B110","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/j.0818-9641.2004.01286.x","article-title":"Aluminium Compounds for Use in Vaccines","volume":"82","author":"Lindblad","year":"2004","journal-title":"Immunol Cell Biol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.toxlet.2011.03.001","article-title":"Progress in Understanding Adjuvant Immunotoxicity Mechanisms","volume":"203","author":"Batista-Duharte","year":"2011","journal-title":"Toxicol Letters"},{"key":"B112","doi-asserted-by":"publisher","first-page":"e4028","DOI":"10.1371\/journal.pone.0004028","article-title":"Safety, Humoral and Cell Mediated Immune Responses to Two Formulations of an Inactivated, Split-Virion Influenza a\/H5n1 Vaccine in Children","volume":"3","author":"Chotpitayasunondh","year":"2008","journal-title":"PLoS One"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa073121","article-title":"Barrett Pn. A Clinical Trial of a Whole-Virus H5n1 Vaccine Derived From Cell Culture","volume":"358","author":"Ehrlich","year":"2008","journal-title":"N Engl J Med"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.4161\/hv.7.12.18322","article-title":"Immunogenicity and Safety of the HPV-16\/18 As04-Adjuvanted Vaccine Administered as a 2-Dose Schedule Compared With the Licensed 3-Dose Schedule: Results From a Randomized Study","volume":"7","author":"Romanowski","year":"2011","journal-title":"Hum Vaccin"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2007.08.039","article-title":"A Case of Recurrent Sterile Abscesses Following Vaccination: Delayed Hypersensitivity to Aluminum","volume":"152","author":"Lehman","year":"2008","journal-title":"J Pediatrics"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0b013e31825228cf","article-title":"Hypersensitivity Reactions to Vaccine Constituents: A Case Series and Review of the Literature","volume":"23","author":"Leventhal","year":"2012","journal-title":"Dermatitis"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1111\/pde.13390","article-title":"Delayed-Type Hypersensitivity to Vaccine Aluminum Adjuvant Causing Subcutaneous Leg Mass and Urticaria in a Child","volume":"35","author":"Gordon","year":"2018","journal-title":"Pediatr Dermatol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.03.036","article-title":"Persistent Itching Nodules After the Fourth Dose of Diphtheria\u2013Tetanus Toxoid Vaccines Without Evidence of Delayed Hypersensitivity to Aluminium","volume":"22","author":"Netterlid","year":"2004","journal-title":"Vaccine"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-005-1704-1","article-title":"Nineteen Cases of Persistent Pruritic Nodules and Contact Allergy to Aluminium After Injection of Commonly Used Aluminium-Adsorbed Vaccines","volume":"164","author":"Bergfors","year":"2005","journal-title":"Eur J Pediatr"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00165-2","article-title":"Aluminum Toxicokinetics Regarding Infant Diet and Vaccinations","volume":"20","author":"Keith","year":"2002","journal-title":"Vaccine"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.09.124","article-title":"Updated Aluminum Pharmacokinetics Following Infant Exposures Through Diet and Vaccination","volume":"29","author":"Mitkus","year":"2011","journal-title":"Vaccine"},{"key":"B122","volume-title":"U.S. FDA C for BE and. Common Ingredients in U.S. Licensed Vaccines","author":"Woodcock","year":"2019"},{"key":"B123","first-page":"1","volume-title":"The Hazards of Immunization","author":"Wilson","year":"1967"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2007.113159","article-title":"Mercury, Vaccines, and Autism: One Controversy, Three Histories","volume":"98","author":"Baker","year":"2008","journal-title":"Am J Public Health"},{"key":"B125","first-page":"1","article-title":"Water Soluble Metallic Organic Compound and Process of Making the Same","volume":"3","author":"Kharasch","year":"1926","journal-title":"United States Patent Office"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1542\/peds.107.5.1147","article-title":"An Assessment of Thimerosal Use in Childhood Vaccines","volume":"107","author":"Ball","year":"2001","journal-title":"Pediatrics"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(81)34945-8","article-title":"Delayed Hypersensitivity to Thimerosal in Soft Contact Lens Wearers","volume":"88","author":"Wilson","year":"1981","journal-title":"Ophthalmology"},{"key":"B128","volume-title":"Extraction and Determination of Thiomersal in Cosmetic, Drugs and Vaccines Using Pulsed Electromembrane Extraction Technique Followed by Flow Injection Cold Vapor Atomic Absorption Spectrometry","author":"Morardi","year":"2016"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.adengl.2017.12.011","article-title":"Diagnostic Tools to Use When We Suspect an Allergic Reaction to a Tattoo: A Proposal Based on Cases at Our Hospital","volume":"109","author":"Gonz\u00e1lez-Villanueva","year":"2018","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas (English Edition)"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10408449509089885","article-title":"Minamata Disease: Methylmercury Poisoning in Japan Caused by Environmental Pollution","volume":"25","author":"Harada","year":"1995","journal-title":"Crit Rev Toxicol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1126\/science.181.4096.230","article-title":"Methylmercury Poisoning in Iraq","volume":"181","author":"Bakir","year":"1973","journal-title":"Science"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1309\/5HY1-V3NE-2LFL-P9MT","article-title":"The Toxicology of Mercury","volume":"33","author":"Broussard","year":"2002","journal-title":"Lab Med"},{"key":"B133","first-page":"144 p","volume-title":"An SAB Report: Review of the EPA Draft Mercury Study Report to Congress","year":"1997"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-3363","article-title":"Mercury Levels in Newborns and Infants After Receipt of Thimerosal-Containing Vaccines","volume":"121","author":"Pichichero","year":"2008","journal-title":"Pediatrics"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60678-8","article-title":"Addressing the Vaccine Confidence Gap","volume":"378","author":"Larson","year":"2011","journal-title":"Lancet"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.18.1763","article-title":"Limiting Infant Exposure to Thimerosal in Vaccines and Other Sources of Mercury","volume":"282","author":"Halsey","year":"1999","journal-title":"JAMA"},{"key":"B137","volume-title":"Emea Public Statement on Thiomersal in Vaccines for Human Use","year":"2004"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1991.tb01694.x","article-title":"A Probable Role for Vaccines Containing Thimerosal in Thimerosal Hypersensitivity","volume":"24","author":"Osawa","year":"1991","journal-title":"Contact Dermatitis"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1996.tb02174.x","article-title":"Hypersensitivity to Thimerosal: The Sensitizing Moiety","volume":"34","author":"Gon\u00e7alo","year":"1996","journal-title":"Contact Dermatitis"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1994.tb02022.x","article-title":"Sensitization to Thimerosal (Merthiolate) Is Still Present Today","volume":"31","author":"Veen","year":"1994","journal-title":"Contact Dermatitis"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1988.tb02809.x","article-title":"Thiomersal Allergy and Vaccination Reactions","volume":"18","author":"Cox","year":"1988","journal-title":"Contact Dermatitis"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.12.971","article-title":"Vaccine-Associated Hypersensitivity","volume":"141","author":"McNeil","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B143","unstructured":"Institute for Vaccine Safety || Thimerosal Content in Some Us Licensed Vaccines2019"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)11096-0","article-title":"Ileal-Lymphoid-Nodular Hyperplasia, non-Specific Colitis, and Pervasive Developmental Disorder in Children","volume":"351","author":"Wakefield","year":"1998","journal-title":"Lancet"},{"key":"B145","unstructured":"Deer byB\n          Revealed: MMR Research Scandal2004"},{"key":"B146","volume-title":"Masern-Mumps-R\u00f6teln-Impfung: Wie Ein Impfstoff Zu Unrecht in Misskredit Gebracht Wurde","author":"\u00c4rzteblatt","year":"2007"},{"key":"B147","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S0140-6736(04)15715-2","article-title":"Retraction of an Interpretation","volume":"363","author":"Murch","year":"2004","journal-title":"Lancet"},{"key":"B148","volume-title":"Andrew Wakefield Erh\u00e4lt Berufsverbot","author":"Gless","year":"2010"},{"key":"B149","volume-title":"The CNN Wire Staff. Autism Study Doctor Barred for \u201cSerious Misconduct\u201d","author":"Zucker","year":"2010"},{"key":"B150","volume-title":"Forschungsskandal: Britischer Autismus-Arzt Erh\u00e4lt Berufsverbot","author":"Klusmann","year":"2010"},{"key":"B151","doi-asserted-by":"publisher","first-page":"e2919","DOI":"10.7759\/cureus.2919","article-title":"The Anti-vaccination Movement: A Regression in Modern Medicine","volume":"10","author":"Hussain","year":"2018","journal-title":"Cureus"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1016\/S0749-3797(03)00113-2","article-title":"Autism and Thimerosal-Containing Vaccines","volume":"25","author":"Stehr-Green","year":"2003","journal-title":"Am J Prev Med"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2003-1177-L","article-title":"Thimerosal Exposure in Infants and Developmental Disorders: A Retrospective Cohort Study in the United Kingdom Does Not Support a Causal Association","volume":"114","author":"Andrews","year":"2004","journal-title":"Pediatrics"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2003-1176-L","article-title":"Thimerosal Exposure in Infants and Developmental Disorders: A Prospective Cohort Study in the United Kingdom Does Not Support a Causal Association","volume":"114","author":"Heron","year":"2004","journal-title":"Pediatrics"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17020-7","article-title":"Mmr Vaccination and Pervasive Developmental Disorders: A Case-Control Study","volume":"364","author":"Smeeth","year":"2004","journal-title":"Lancet"},{"key":"B156","doi-asserted-by":"crossref","first-page":"CD004407.pub2","DOI":"10.1002\/14651858.CD004407.pub2","article-title":"Vaccines for Measles, Mumps and Rubella in Children","volume-title":"Cochrane Database of Systematic Reviews","author":"Demicheli","year":"2005"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100407","article-title":"Vaccines and Autism: Evidence Does Not Support a Causal Association","volume":"82","author":"DeStefano","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2010-0309","article-title":"Prenatal and Infant Exposure to Thimerosal From Vaccines and Immunoglobulins and Risk of Autism","volume":"126","author":"Price","year":"2010","journal-title":"Pediatrics"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.01.093","article-title":"The Combined Measles, Mumps, and Rubella Vaccines and the Total Number of Vaccines Are Not Associated With Development of Autism Spectrum Disorder: The First Case\u2013Control Study in Asia","volume":"30","author":"Uno","year":"2012","journal-title":"Vaccine"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-1079","article-title":"Safety of Vaccines Used for Routine Immunization of US Children: A Systematic Review","volume":"134","author":"Maglione","year":"2014","journal-title":"Pediatrics"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.04.085","article-title":"Vaccines Are Not Associated With Autism: An Evidence-Based Meta-Analysis of Case-Control and Cohort Studies","volume":"32","author":"Taylor","year":"2014","journal-title":"Vaccine"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.3077","article-title":"Autism Occurrence by MMR Vaccine Status Among US Children With Older Siblings With and Without Autism","volume":"313","author":"Jain","year":"2015","journal-title":"JAMA"},{"key":"B163","doi-asserted-by":"publisher","first-page":"1","DOI":"10.24095\/hpcdp.37.1.01","article-title":"Environmental Factors Associated With Autism Spectrum Disorder: A Scoping Review for the Years 2003\u20132013","volume":"37","author":"Ng","year":"2017","journal-title":"Health Promot Chronic Dis Prev Can"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.7326\/M18-2101","article-title":"Measles, Mumps, Rubella Vaccination and Autism: A Nationwide Cohort Study","volume":"170","author":"Hviid","year":"2019","journal-title":"Ann Intern Med"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1016\/j.etap.2014.10.005","article-title":"Autism: A Form of Lead and Mercury Toxicity","volume":"38","author":"Yassa","year":"2014","journal-title":"Environ Toxicol Pharmacol"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1016\/j.tics.2011.07.003","article-title":"Genetics of Autism Spectrum Disorders","volume":"15","author":"Geschwind","year":"2011","journal-title":"Trends Cogn Sci"},{"key":"B167","article-title":"Chapter 21 - Genetics of Autism Spectrum Disorder","volume-title":"Handbook of Clinical Neurology","author":"Ramaswami","year":"2018"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.13717","article-title":"Progress in the Genetics of Autism Spectrum Disorder","volume":"60","author":"Woodbury-Smith","year":"2018","journal-title":"Dev Med Child Neurol"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2017.19.4\/mdavidson","article-title":"Vaccination as a Cause of Autism\u2014Myths and Controversies","volume":"19","author":"Davidson","year":"2017","journal-title":"Dialogues Clin Neurosci"},{"key":"B170","doi-asserted-by":"publisher","first-page":"e1003542","DOI":"10.1371\/journal.pcbi.1003542","article-title":"Ten Simple Rules for the Care and Feeding of Scientific Data","volume":"10","author":"Goodman","year":"2014","journal-title":"PLoS Comput Biol"},{"key":"B171","article-title":"Scientific Method","volume-title":"Stanford Encyclopedie of Philosophy Archive","author":"Andersen","year":"2015"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.16.6077","article-title":"Cationic Liposome-Mediated Rna Transfection","volume":"86","author":"Malone","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"B173","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.coi.2020.01.008","article-title":"Recent Advances in mRNA Vaccine Technology","volume":"65","author":"Pardi","year":"2020","journal-title":"Curr Opin Immunol"},{"key":"B174","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-540-72167-3_11","article-title":"Vaccination With Messenger RNA (mRNA)","volume-title":"Toll-Like Receptors (Tlrs) and Innate Immunity","author":"Pascolo","year":"2008"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1355245","article-title":"Mechanism of Action of mRNA-Based Vaccines","volume":"16","author":"Iavarone","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1007\/s12274-018-2091-z","article-title":"Recent Advances in Mrna Vaccine Delivery","volume":"11","author":"Tan","year":"2018","journal-title":"Nano Res"},{"key":"B177","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jmv.26922","article-title":"Vaccination Hesitancy and the \u201cMyth\u201d on Mrna-Based Vaccines in Italy in the COVID-19 Era: Does Urgency Meet Major Safety Criteria","volume":"93","author":"Chirumbolo","year":"2021","journal-title":"J Med Virol"},{"key":"B178","volume-title":"Macht Unfruchtbar Und Ver\u00e4ndert Die Dna? Die Mythen zum Corona-Impfstoff im Check","author":"Kreisel","year":"2020"},{"key":"B179","volume-title":"Bill Gates Says mRNA Covid-19 Vaccine Will Alter Your Dna: Here Is the Truth","author":"Sandhu","year":"2020"},{"key":"B180","volume-title":"Ver\u00e4ndert Der Mrna-Impfstoff Unser Erbgut","author":"Stoppel","year":"2020"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1007\/s000180050207","article-title":"Human Extracellular Ribonucleases: Multiplicity, Molecular Diversity and Catalytic Properties of the Major Rnase Types","volume":"54","author":"Sorrentino","year":"1998","journal-title":"CMLS Cell Mol Life Sci"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3302964","article-title":"Spontaneous Cellular Uptake of Exogenous Messenger RNA in Vivo Is Nucleic Acid-Specific, Saturable and Ion Dependent","volume":"14","author":"Probst","year":"2007","journal-title":"Gene Ther"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.4161\/rna.22269","article-title":"Developing mRNA-vaccine Technologies","volume":"9","author":"Schlake","year":"2012","journal-title":"RNA Biol"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1995.tb44729.x","article-title":"Potential DNA Vaccine Integration Into Host Cell Genome","volume":"772","author":"Nichols","year":"1995","journal-title":"Ann NY Acad Sci"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1089\/10430349950018517","article-title":"Plasmid DNA Malaria Vaccine: The Potential for Genomic Integration After Intramuscular Injection","volume":"10","author":"Martin","year":"1999","journal-title":"Hum Gene Ther"},{"key":"B186","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000053993","article-title":"Plasmid DNA Vaccines: Assay for Integration Into Host Genomic Dna","volume":"104","author":"Ledwith","year":"2000","journal-title":"Dev Biol (Basel)"},{"key":"B187","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1385\/1-59745-168-1:23","article-title":"Vaccination With Messenger Rna","volume-title":"DNA Vaccines","author":"Pascolo","year":"2006"},{"key":"B188","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.febslet.2004.03.066","article-title":"Replicable and Recombinogenic Rnas","volume":"567","author":"Chetverin","year":"2004","journal-title":"FEBS Lett"},{"key":"B189","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1128\/MR.56.1.61-79.1992","article-title":"Rna Recombination in Animal and Plant Viruses","volume":"56","author":"Lai","year":"1992","journal-title":"Microbiol Rev"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2003.11.015","article-title":"Generalized RNA-Directed Recombination of RNA","volume":"10","author":"Riley","year":"2003","journal-title":"Chem Biol"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2015.1001244","article-title":"Introduction to RNA-based Vaccines and Therapeutics","volume":"14","author":"Geall","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S39810","article-title":"Development of Nucleic Acid Vaccines: Use of Self-Amplifying RNA in Lipid Nanoparticles","volume":"9","author":"Rodr\u00edguez-Gasc\u00f3n","year":"2014","journal-title":"Int J Nanomedicine"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0b013e31815ce501","article-title":"Results of the First Phase I\/II Clinical Vaccination Trial With Direct Injection of mRNA","volume":"31","author":"Weide","year":"2008","journal-title":"J\u00a0Immunother"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.0597","article-title":"Overall Survival Analysis of a Phase Ii Randomized Controlled Trial of a Poxviral-Based Psa-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer","volume":"28","author":"Kantoff","year":"2010","journal-title":"J Clin Oncol"},{"key":"B195","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-14-748","article-title":"Phase Ib Study Evaluating a Self-Adjuvanted mRNA Cancer Vaccine (Rnactive\u00ae) Combined With Local Radiation as Consolidation and Maintenance Treatment for Patients With Stage IV Non-Small Cell Lung Cancer","volume":"14","author":"Sebastian","year":"2014","journal-title":"BMC Cancer"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.4121","article-title":"Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (Trimixdc-Mel) Plus Ipilimumab in Patients With Pretreated Advanced Melanoma","volume":"34","author":"Wilgenhof","year":"2016","journal-title":"JCO"},{"key":"B197","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ymthe.2017.10.020","article-title":"Combination Immunotherapy of MUC1 mRNA Nano-Vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer","volume":"26","author":"Liu","year":"2018","journal-title":"Mol Ther"},{"key":"B198","volume-title":"Ema Recommends First COVID-19 Vaccine for Authorisation in the EU","author":"Pinho","year":"2020"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2639-4","article-title":"Phase I\/II Study of COVID-19 Rna Vaccine BNT162b1 in Adults","volume":"586","author":"Mulligan","year":"2020","journal-title":"Nature"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 Mrna Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2027906","article-title":"Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates","volume":"383","author":"Walsh","year":"2020","journal-title":"N Engl J Med"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117793","article-title":"Induction of Cross-Reactive Anti-Dsdna Antibodies in Preautoimmune Nzb\/Nzw Mice by Immunization With Bacterial Dna","volume":"95","author":"Gilkeson","year":"1995","journal-title":"J Clin Invest"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2013.09.002","article-title":"Challenges and Advances Towards the Rational Design of mRNA Vaccines","volume":"19","author":"Pollard","year":"2013","journal-title":"Trends Mol Med"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.9.3799","article-title":"Pervasive CpG Suppression in Animal Mitochondrial Genomes","volume":"91","author":"Cardon","year":"1994","journal-title":"PNAS"},{"key":"B205","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1089\/hum.1997.8.3-293","article-title":"Do DNA Vaccines Induce Autoimmune Disease","volume":"8","author":"Mor","year":"1997","journal-title":"Hum Gene Ther"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-59745-399-8_21","article-title":"State of the Art and Future Needs in Upstream Processing","volume":"24","author":"Genzel","year":"2007","journal-title":"Anim Cell Biotechnol"},{"key":"B207","first-page":"1","article-title":"Viral Vaccine Production in Cell Culture","volume-title":"Encyclopedia of Industrial Biotechnology","author":"Aunin\u0161","year":"2009"},{"key":"B208","doi-asserted-by":"publisher","first-page":"12.09.20245175","DOI":"10.1101\/2020.12.09.20245175","article-title":"Bnt162b2 Induces Sars-Cov-2-Neutralising Antibodies and T Cells in Humans","volume":"2020","author":"Sahin","year":"2020","journal-title":"medRxiv"},{"key":"B209","doi-asserted-by":"publisher","first-page":"09.08.280818","DOI":"10.1101\/2020.09.08.280818","article-title":"A Prefusion Sars-Cov-2 Spike RNA Vaccine Is Highly Immunogenic and Prevents Lung Infection in Non-Human Primates","volume":"2020","author":"Vogel","year":"2020","journal-title":"bioRxiv"},{"key":"B210","volume-title":"Assessment Report: Comirnaty","year":"2021"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1111\/all.14711","article-title":"Allergic Reactions to the First Covid-19 Vaccine: A Potential Role of Polyethylene Glycol","author":"Cabanillas","year":"2020","journal-title":"Allergy"},{"key":"B212","volume-title":"Mrna Vaccines Against Covid-19: Pfizer-BioNTech COVID-19 vaccine BNT162b2","year":"2020"},{"key":"B213","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.jaip.2018.12.003","article-title":"Immediate Hypersensitivity to Polyethylene Glycols and Polysorbates: More Common Than We Have Recognized","volume":"7","author":"Stone","year":"2019","journal-title":"J Allergy Clin Immunology: In Practice"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.04.005","article-title":"Radiocontrast Media Hypersensitivity: Skin Testing Differentiates Allergy From Nonallergic Reactions and Identifies a Safe Alternative as Proven by Intravenous Provocation","volume":"7","author":"Trautmann","year":"2019","journal-title":"J Allergy Clin Immunology: In Practice"},{"key":"B215","first-page":"1","article-title":"Regulation (Ec) No 1333\/2008 of the European Parliament and of the Council of 16 December 2008 on Food Additives","year":"2008","journal-title":"Official Journal of the European Union"},{"key":"B216","doi-asserted-by":"publisher","first-page":"e05293","DOI":"10.2903\/j.efsa.2018.5293","article-title":"Refined Exposure Assessment of Polyethylene Glycol (E 1521) From Its Use as a Food Additive","volume":"16","author":"Younes","year":"2018","journal-title":"EFSA J"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1111\/cea.12760","article-title":"Immediate-Type Hypersensitivity to Polyethylene Glycols: A Review","volume":"46","author":"Wenande","year":"2016","journal-title":"Clin Exp Allergy"},{"key":"B218","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmj.n120","article-title":"Vaccinating Against Covid-19 in People Who Report Allergies","author":"Glover","year":"2021","journal-title":"BMJ"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2020.12.020","article-title":"Anaphylaxis to the First Covid-19 Vaccine: Is Polyethylene Glycol (PEG) the Culprit","volume":"126","author":"Garvey","year":"2021","journal-title":"Br J Anaesth"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.12.1003","article-title":"Anaphylaxis After Vaccination Reported to the Vaccine Adverse Event Reporting System, 1990-2016","volume":"143","author":"Su","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2028436","article-title":"Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults","volume":"383","author":"Anderson","year":"2020","journal-title":"N Engl J Med"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2032195","article-title":"Durability of Responses After SARS-CoV-2 mRNA-1273 Vaccination","volume":"384","author":"Widge","year":"2020","journal-title":"N Engl J Med"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA Vaccine Against Sars-CoV-2 \u2014 Preliminary Report","volume":"383","author":"Jackson","year":"2020","journal-title":"N Engl J Med"},{"key":"B224","volume-title":"EMA Receives Application for Conditional Marketing Authorisation of Moderna Covid-19 Vaccine","author":"Pinho","year":"2020"},{"key":"B225","volume-title":"Assessment Report: Covid-19 Vaccine Moderna","year":"2021"},{"key":"B226","volume-title":"Ema Recommends Covid-19 Vaccine Moderna for Authorisation in the EU","author":"Glanville","year":"2021"},{"key":"B227","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1056\/NEJMp2030600","article-title":"No-Fault Compensation for Vaccine Injury \u2014 The Other Side of Equitable Access to Covid-19 Vaccines","volume":"383","author":"Halabi","year":"2020","journal-title":"N Engl J Med"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-020-00675-8","article-title":"Mistrust in Biomedical Research and Vaccine Hesitancy: The Forefront Challenge in the Battle Against COVID-19 in Italy","volume":"35","author":"Palamenghi","year":"2020","journal-title":"Eur J Epidemiol"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1038\/22867","article-title":"How to Restore Public Trust in Science","volume":"400","author":"Haerlin","year":"1999","journal-title":"Nature"},{"key":"B230","doi-asserted-by":"publisher","first-page":"eabd4563","DOI":"10.1126\/sciadv.abd4563","article-title":"Model Uncertainty, Political Contestation, and Public Trust in Science: Evidence From the COVID-19 Pandemic","volume":"6","author":"Kreps","year":"2020","journal-title":"Sci Adv"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.663280\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T09:30:06Z","timestamp":1623317406000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.663280\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,10]]},"references-count":230,"alternative-id":["10.3389\/fimmu.2021.663280"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.663280","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,10]]},"article-number":"663280"}}